Literature DB >> 23777669

Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation.

Hong In Yoon1, Jee Suk Chang, Joon Seok Lim, Sung Hoon Noh, Woo Jin Hyung, Ji Yeong An, Yong Chan Lee, Sun Young Rha, Kyung Hwan Kim, Woong Sub Koom.   

Abstract

PURPOSE: To determine the recurrent nodal gross tumor volume (rnGTV) based on CT-guided vascular structure to refine the clinical target volume (CTV) delineation in postoperative radiotherapy for advanced gastric cancer following radical gastrectomy with D2 dissection.
MATERIALS AND METHODS: We retrospectively reviewed follow-up images from 91 patients with their first regional recurrence after D2 dissection in stage III gastric cancer with N3 disease. We defined rnGTV as recurrent nodes shown in follow-up CT images, in which one diagnostic radiologist with specialty of gastrointestinal tract investigated. We drew rnGTVs at the equivalent location based on the same vessels of reference comparing CT images to recurrence CT images.
RESULTS: We propose vessel-based locations of rnGTVs on CT images with axial and coronal views. We show different patterns of regional recurrence according to the location of primary gastric cancer using CT and digitally reconstructed radiograph (DRR) images. Frequently recurred sites, overlapped by more than five rnGTVs, are depicted in a DRR image.
CONCLUSIONS: This study suggests vessel-based delineations of rnGTVs on CT images depending on nodal recurrence sites from follow-up images after D2 lymphadenectomy. Our results could help reduce the inter-observer variation of CTV delineation after D2 dissection in gastric cancer.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CT-guidance; Gastric cancer; Gross tumor volume; Recurrent node; Vasculature

Mesh:

Year:  2013        PMID: 23777669     DOI: 10.1016/j.radonc.2013.05.025

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Clinical target volume in postoperative radiotherapy for gastric cancer: identification of major difficulties and controversies.

Authors:  J Socha; G Wołąkiewicz; E Wasilewska-Teśluk; P Janiga; T Kondraciuk; A Majewska; K Olearski; L Kępka
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

2.  The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer.

Authors:  Cem Onal; Mustafa Cengiz; Ozan C Guler; Yemliha Dolek; Serdar Ozkok
Journal:  Br J Radiol       Date:  2017-03-24       Impact factor: 3.039

Review 3.  Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?

Authors:  Jee Suk Chang; Woong Sub Koom; Youngin Lee; Hong In Yoon; Hyung Sik Lee
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy.

Authors:  Jing Xu; Li Shen; Yongjie Shui; Wei Yu; Qingqu Guo; Risheng Yu; Yulian Wu; Qichun Wei
Journal:  Cancer Med       Date:  2020-05-18       Impact factor: 4.452

Review 5.  Progress of preoperative and postoperative radiotherapy in gastric cancer.

Authors:  Nan Zhang; Qian Fei; Jiajia Gu; Li Yin; Xia He
Journal:  World J Surg Oncol       Date:  2018-09-13       Impact factor: 2.754

Review 6.  Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition.

Authors:  Jing Xu; Jonathan Zhu; Qichun Wei
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

7.  Radiotherapy Combined with Chemotherapy for Regional Lymph Node Recurrence in Gastric Cancer.

Authors:  Liang Cai; Ganlu Ouyang; Xin Wang; Zhiping Li; Yali Shen
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

8.  Identification of Patients With Locally Advanced Gastric Cancer Who May Benefit From Adjuvant Chemoradiotherapy After D2 dissection: A Propensity Score Matching Analysis.

Authors:  Shu-Bei Wang; Wei-Xiang Qi; Jia-Yi Chen; Cheng Xu; Wei-Guo Cao; Rong Cai; Lu Cao; Gang Cai
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

9.  Preoperative Chemoradiotherapy Versus Postoperative Chemoradiotherapy for Patients With Locally Advanced Gastric Cancer: A Retrospective Study Based on Propensity Score Analyses.

Authors:  Wang Yang; Menglong Zhou; Guichao Li; Lijun Shen; Yan Wang; Hui Zhang; Yaqi Wang; Jing Zhang; Xiaoyang Sun; Zhiyuan Zhang; Wei Zou; Zhen Zhang
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.